shutterstock_738938950_alla_vasylenko
alla vasylenko / Shutterstock.com
26 April 2019Americas

LSPN 19: Two bites at the apple here to stay, says Alkermes director

Petitioners will continue to be able to launch litigation simultaneously before both the district court and the Patent Trial and Appeal Board (PTAB), effectively having two bites at the apple, according to John Kirkland, director of IP at biopharmaceutical company Alkermes.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
21 April 2022   Irish biopharmaceutical company Alkermes has entered arbitration proceedings over two license agreements with Johnson & Johnson subsidiary Janssen Pharmaceuticals.

More on this story

Americas
21 April 2022   Irish biopharmaceutical company Alkermes has entered arbitration proceedings over two license agreements with Johnson & Johnson subsidiary Janssen Pharmaceuticals.

More on this story

Americas
21 April 2022   Irish biopharmaceutical company Alkermes has entered arbitration proceedings over two license agreements with Johnson & Johnson subsidiary Janssen Pharmaceuticals.